Assessment of What Patients and Healthcare Providers Value

Overview

To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

Full Title of Study: “”What Do You Value?” A Survey Study Assessing How Patients and Health Care Providers Weigh the Different Components of the Value Equation”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: August 11, 2022

Detailed Description

PRIMARY OBJECTIVE: I. To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience). SECONDARY OBJECTIVES: I. To assess which attributes of value (i.e., outcomes, QOL, cost, experience) health care providers (i.e., physicians, nurses, administrators) feel are most important in health care delivery. II. To assess how these patients' views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence). III. To assess how patients' view differ to health providers. OUTLINE: Patients and healthcare providers complete a survey over 10-15 minutes.

Interventions

  • Other: Survey Administration
    • Complete survey

Arms, Groups and Cohorts

  • Observational (survey administration)
    • Patients and healthcare providers complete a survey over 10-15 minutes.

Clinical Trial Outcome Measures

Primary Measures

  • Importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)
    • Time Frame: Survey completion up to 1 year
    • We will calculate the mean rank of patients yielding usable data and its corresponding 95% confidence interval. Patient characteristics and survey items will be summarized using descriptive statistics, including means, standard deviations (SDs), proportions, range, and 95% confidence intervals (CIs), etc.

Secondary Measures

  • Most important attributes of value to healthcare providers
    • Time Frame: Survey completion up to 1 year
    • Provider characteristics and survey items will be summarized using descriptive statistics, including means, SDs, proportions, range, and 95% CIs, etc.
  • Importance care providers (i.e., physicians, nurses, administrators) place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)
    • Time Frame: Survey completion up to 1 year
    • Chi-square tests (or Fisher’s exact test) will be used to compare the results between patients and providers.

Participating in This Clinical Trial

Inclusion Criteria

  • Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma – Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers – Able to understand the description of the study and willing to participate Exclusion Criteria:

  • Inability to read and answer questions in English

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • M.D. Anderson Cancer Center
  • Collaborator
    • National Cancer Institute (NCI)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Matthew H Katz, Principal Investigator, M.D. Anderson Cancer Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.